Literature DB >> 33133776

Molecular Biomarkers for Glaucoma.

Gala Beykin1, Jeffrey L Goldberg1.   

Abstract

PURPOSE OF REVIEW: This article summarizes the current studies on molecular biomarkers with potential implications in diagnosis, prognosis, and response to treatment in patients with glaucoma. RECENT
FINDINGS: Important advances have occurred in the understanding of the pathogenesis of glaucomatous neurodegeneration. Protein biomarkers associated with inflammatory, neurodegenerative, and other molecular pathways have been described in glaucoma patients in tear film, aqueous fluid, vitreous fluid, and serum, however, we are still far from having a clear picture of the whole molecular network that relates to the disease and its implications in clinical use.
SUMMARY: Although more studies are needed, current and emerging molecular biomarkers candidates in glaucoma may eventually transition into clinical use and contribute to outline the concept of precision medicine and precision health in glaucoma.

Entities:  

Keywords:  Glaucoma; biomarkers; optic nerve degeneration

Year:  2019        PMID: 33133776      PMCID: PMC7597904          DOI: 10.1007/s40135-019-00213-0

Source DB:  PubMed          Journal:  Curr Ophthalmol Rep        ISSN: 2167-4868


  54 in total

1.  Differential protein expression in tears of patients with primary open angle and pseudoexfoliative glaucoma.

Authors:  Damiana Pieragostino; Sonia Bucci; Luca Agnifili; Vincenzo Fasanella; Simona D'Aguanno; Alessandra Mastropasqua; Marco Ciancaglini; Leonardo Mastropasqua; Carmine Di Ilio; Paolo Sacchetta; Andrea Urbani; Piero Del Boccio
Journal:  Mol Biosyst       Date:  2011-11-29

Review 2.  Ciliary neurotrophic factor (CNTF): New facets of an old molecule for treating neurodegenerative and metabolic syndrome pathologies.

Authors:  Sarah Pasquin; Mukut Sharma; Jean-François Gauchat
Journal:  Cytokine Growth Factor Rev       Date:  2015-07-03       Impact factor: 7.638

3.  Neural stem cell-based intraocular administration of ciliary neurotrophic factor attenuates the loss of axotomized ganglion cells in adult mice.

Authors:  Kai Flachsbarth; Katharina Kruszewski; Gila Jung; Wanda Jankowiak; Kristoffer Riecken; Lars Wagenfeld; Gisbert Richard; Boris Fehse; Udo Bartsch
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-09-30       Impact factor: 4.799

4.  [Options for correction of endothelial dysfunction and oxidative stress in patients with primary open-angle glaucoma].

Authors:  T N Malishevskaia; I G Dolgova
Journal:  Vestn Oftalmol       Date:  2014 Sep-Oct

5.  Variability of serum oxidative stress biomarkers relative to biochemical data and clinical parameters of glaucoma patients.

Authors:  Kaya N Engin; Bülent Yemişci; Ulviye Yiğit; Ahmet Ağaçhan; Cihan Coşkun
Journal:  Mol Vis       Date:  2010-07-09       Impact factor: 2.367

6.  The number of people with glaucoma worldwide in 2010 and 2020.

Authors:  H A Quigley; A T Broman
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

7.  Inflammation-related cytokines of aqueous humor in acute primary angle-closure eyes.

Authors:  Wenbin Huang; Shida Chen; Xinbo Gao; Min Yang; Jing Zhang; Xingyi Li; Wei Wang; Minwen Zhou; Xinyu Zhang; Xiulan Zhang
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-24       Impact factor: 4.799

8.  [Endothelins and dopamine levels in tears for assessment of neurovascular disorders in glaucoma].

Authors:  T A Pavlenko; A R Kim; A Yu Kurina; N G Davydova; E M Kolomojceva; N B Chesnokova; M V Ugrumov
Journal:  Vestn Oftalmol       Date:  2018

9.  Opposing roles for membrane bound and soluble Fas ligand in glaucoma-associated retinal ganglion cell death.

Authors:  Meredith S Gregory; Caroline G Hackett; Emma F Abernathy; Karen S Lee; Rebecca R Saff; Andreas M Hohlbaum; Krishna-Sulayman L Moody; Maura W Hobson; Alexander Jones; Paraskevi Kolovou; Saoussen Karray; Andrea Giani; Simon W M John; Dong Feng Chen; Ann Marshak-Rothstein; Bruce R Ksander
Journal:  PLoS One       Date:  2011-03-29       Impact factor: 3.240

10.  Intraocular cytokine profile and autoimmune reactions in retinitis pigmentosa, age-related macular degeneration, glaucoma and cataract.

Authors:  Josianne C Ten Berge; Zainab Fazil; Ingeborgh van den Born; Roger C W Wolfs; Marco W J Schreurs; Wim A Dik; Aniki Rothova
Journal:  Acta Ophthalmol       Date:  2018-10-08       Impact factor: 3.761

View more
  2 in total

Review 1.  Pupillary response to chromatic light stimuli as a possible biomarker at the early stage of glaucoma: a review.

Authors:  Carla Arévalo-López; Silvia Gleitze; Samuel Madariaga; Iván Plaza-Rosales
Journal:  Int Ophthalmol       Date:  2022-07-04       Impact factor: 2.031

Review 2.  Clinical Tear Fluid Proteomics-A Novel Tool in Glaucoma Research.

Authors:  Janika Nättinen; Ulla Aapola; Praveena Nukareddy; Hannu Uusitalo
Journal:  Int J Mol Sci       Date:  2022-07-23       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.